Literature DB >> 1673040

Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by Simian immunodeficiency virus.

P R Clapham1, D Blanc, R A Weiss.   

Abstract

Human CD4 was expressed on a range of mammalian cell lines. CD4+ non-primate cells, derived from rat, hamster, mink, cat, and rabbit, bind recombinant gp120 of human immunodeficiency virus type 1 (HIV-1) but are resistant to HIV-1 infection. CD4 expression on various human, rhesus, and African green monkey cell lines confers differential susceptibilities for HIV-1, HIV-2, and simian immunodeficiency (SIV) strains. For example, CD4+ TE671 rhabdomyosarcoma cells are sensitive to HIV-1 and HIV-2 but resistant to SIV, whereas CD4+ U87 glioma cells are resistant to HIV-1 infection but sensitive to HIV-2 and SIV. HIV-1 infection was not dependent on human major histocompatibility class I expression. Studies of cell fusion and of infection by vesicular stomatitis virus pseudotypes bearing HIV-1 and HIV-2 envelopes showed that the differential cell tropisms of HIV-1, HIV-2, and SIV are determined at the cell surface.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673040      PMCID: PMC7131431          DOI: 10.1016/0042-6822(91)90904-p

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  71 in total

1.  Pseudotypes of avian sarcoma viruses with the envelope properties of vesicular stomatitis virus.

Authors:  R A Weiss; D Boettiger; H M Murphy
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

2.  A chink in HIV's armour?

Authors:  P E Stephens; G Clements; G T Yarranton; J Moore
Journal:  Nature       Date:  1990-01-18       Impact factor: 49.962

3.  A CD4 domain important for HIV-mediated syncytium formation lies outside the virus binding site.

Authors:  D Camerini; B Seed
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

4.  Isolation of simian immunodeficiency virus from African green monkeys and seroepidemiologic survey of the virus in various non-human primates.

Authors:  Y Ohta; T Masuda; H Tsujimoto; K Ishikawa; T Kodama; S Morikawa; M Nakai; S Honjo; M Hayami
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

5.  The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

Authors:  G J Clements; M J Price-Jones; P E Stephens; C Sutton; T F Schulz; P R Clapham; J A McKeating; M O McClure; S Thomson; M Marsh
Journal:  AIDS Res Hum Retroviruses       Date:  1991-01       Impact factor: 2.205

6.  Human immunodeficiency virus infection is efficiently mediated by a glycolipid-anchored form of CD4.

Authors:  D C Diamond; R Finberg; S Chaudhuri; B P Sleckman; S J Burakoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

7.  Infection of rabbit T-cell and macrophage lines with human immunodeficiency virus.

Authors:  H Kulaga; T M Folks; R Rutledge; T J Kindt
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Clonal analysis of line XC-tc rat tumour cells (derived from tumour XC) grown in vitro.

Authors:  D SIMKOVIC; J SVOBODA; N VALENTOVA
Journal:  Folia Biol (Praha)       Date:  1963-04       Impact factor: 0.906

9.  Inhibition of the growth of human coronavirus 229E by leupeptin.

Authors:  G Appleyard; M Tisdale
Journal:  J Gen Virol       Date:  1985-02       Impact factor: 3.891

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

View more
  103 in total

1.  Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells.

Authors:  P D Bieniasz; B R Cullen
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells.

Authors:  H C Selinka; A Zibert; E Wimmer
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Human immunodeficiency virus type 2 envelope glycoprotein binds to CD8 as well as to CD4 molecules on human T cells.

Authors:  H Kaneko; L P Neoh; N Takeda; H Akimoto; T Hishikawa; H Hashimoto; S Hirose; S Karaki; M Takiguchi; H Nakauchi; Y Kaneko; N Yamamoto; I Sekigawa
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

4.  Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein.

Authors:  R Bron; P J Klasse; D Wilkinson; P R Clapham; A Pelchen-Matthews; C Power; T N Wells; J Kim; S C Peiper; J A Hoxie; M Marsh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2.

Authors:  N Sol; F Ferchal; J Braun; O Pleskoff; C Tréboute; I Ansart; M Alizon
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4.

Authors:  P R Clapham; A McKnight; R A Weiss
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

7.  Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups.

Authors:  M T Dittmar; G Simmons; S Hibbitts; M O'Hare; S Louisirirotchanakul; S Beddows; J Weber; P R Clapham; R A Weiss
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

8.  Target cell-specific determinants of membrane fusion within the human immunodeficiency virus type 1 gp120 third variable region and gp41 amino terminus.

Authors:  L Bergeron; N Sullivan; J Sodroski
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.

Authors:  T Toyosaki; T Miyazawa; T Furuya; K Tomonaga; Y S Shin; M Okita; Y Kawaguchi; C Kai; S Mori; T Mikami
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120.

Authors:  J A McKeating; C Shotton; J Cordell; S Graham; P Balfe; N Sullivan; M Charles; M Page; A Bolmstedt; S Olofsson
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.